Cell-Matrix interactions, the role of fibronectin and integrins. A survey

Pathologie Biologie

Volumn 60, Issue 1, 2012, Pages 15-19

  Labat Robert, J ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Connective Tissues; Extracellular matrix; Fibronectin; Fibronectin fragments; Integrins; Matricryptins; Proteases; Remodeling

Indexed keywords

FIBRONECTIN; FIBRONECTIN RECEPTOR; INTEGRIN;

ARTICLE; BIOLOGICAL ACTIVITY; CELL INTERACTION; CONCENTRATION (PARAMETERS); EXTRACELLULAR MATRIX; HUMAN; MALNUTRITION; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; NUTRITIONAL STATUS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TISSUE LEVEL;

ANIMALS; CELL COMMUNICATION; DATA COLLECTION; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; INTEGRINS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RECEPTORS, FIBRONECTIN;

EID: 84857031420     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.10.003     Document Type: Article

References (69)

1. Hynes R.O. Fibronectins 1990, Springer.
2. Engel J. Domains in proteins and proteoglycans of the extracellular matrix with functions in assembly and cellular activities. Int J Biol Macromol 1991, 13:147-151.
3. Labat-Robert J., Robert L., Auger C., Lethias C., Garrone R. A fibronectin-like protein in porifera; its role in cell aggregation. Proc Natl Acad Sci U S A 1981, 78:6261-6265.
4. Tamkun J.W., Hynes R.O. Plasma fibronectin is synthesized and secreted by hepatocytes. J Biol Chem 1983, 258:4641-4647.
5. Moretti F.A., Chauhan A.L., Iaconcig A., Porro F., Baralle F.E., Muro A.F. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 2007, 282:28057-28062.
6. Muro A.F., Chauhan A.K., Galovic S., Iaconcig A., Porro F., Stanta G., et al. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 2003, 162:149-151.
7. Kornblihtt A.R., Vibe-Petersen K., Baralle F.E. Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J 1984, 3:221-226.
8. Gutman A., Kornblihtt A.R. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc Natl Acad Sci U S A 1987, 84:7179-7182.
9. Schwarzbauer J.E., Tamkun J.W., Lemischka J.R., Hynes R.O. Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 1983, 35:421-431.
10. Peters J.H., Greasby T., Lane N., Woolf A. Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease. Biomarkers 2009, 14:250-257.
11. Hino K., Shiozawa S., Kuroki Y., Ishikawa H., Shiozawa K., Sekiguchi K., et al. EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum 1995, 38:678-683.
12. Singh P., Reimer C., Peters J.H., Stepp M.A., Hynes R.O., Van de Water L. J The spatial and temporal expression patterns of integrin α9β1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J Invest Dermatol 2004, 123:793-801.
13. Shinde A.V., Bystroff C., Wang C., Vogelezang M., Vincent P.A., Hynes R.O., et al. Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin α9β1-dependent cellular activities. J Biol Chem 2008, 283:2858-2870.
14. Guan J.L., Hynes R.O. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1. Cell 1990, 60:53-61.
15. Hynes R.O. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992, 44:517-518.
16. Ruoslahti E., Pierschbacher M. RGD, a versatile cell recognition signal. Cell 1986, 44:517-518.
17. Schwarbauer J.E., Sechler J.L. Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly. Curr Opin Cell Biol 1999, 11:622-627.
18. Sechler J.L., Cumiskey A.M., Gazzola D.M., Scharzbauer J.E. A novel RGD-independent fibronectin assembly pathway initiated by α4β1 integrin-binding to the alternatively spliced V region. J Cell Sci 2000, 113:1491-1498.
19. Sechler J.L., Rao H., Cumiskey A., Vega-Colon I., Smith M.S., Murata T., et al. A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly. J Cell Biol 2001, 154:1081-1088.
20. Leiss M., Beckmann K., Giros A., Costell M., Fässler R. The role of integrin-binding sites in fibronectin matrix assembly in vivo. Curr Opin Cell Biol 2008, 20:502-507.
21. Sechler J.L., Cumiskey A.M., Gazzolo D.M., Schwarzbauer J.E. A novel RGD-independent fibronectin assembly pathway initiated by α4β1 integrin-binding to the alternatively spliced V region. J Cell Sci 2000, 113:1491-1498.
22. Takahashi S., Leiss M., Moser M., Ohashi T., Kitao T., Heckmann D., et al. The RGD motif in fibronectin is essential for development but dispensable for fibril assembly. J Cell Biol 2007, 178:167-178.
23. Ohashi T., Kiehart D.P., Erickson H.P. Dynamics and elasticity of the fibronectin matrix in living cellculture vizualized by fibronectin-green fluorescent protein. Proc Natl Acad Sci U S A 1999, 96:2153-2158.
24. Wierzbicka-Patynowski I., Schwarzbauer J.E. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003, 118:3269-3276.
25. Hynes R.O. Integrins: bi-directional, allosteric signaling machines. Cell 2002, 110:673-687.
26. Johnson M.S., Lu N., Denessiouk K., Heino J., Gullberg D. Integrins during evolution: evolutionary trees and model organisms. Biochem Byophys Acta 2009, 1788:779-789.
27. Arnaout M.A., Goodman S.L., Xiong J.P. Structure and mechanics of integrin-based cell adhesion. Curr Opin Cell Biol 2007, 19:495-507.
28. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Ann Rev Immunol 2007, 25:619-647.
29. Legate K.R., Wickström, Fässler R. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev 2009, 23:397-418.
30. Luo B.H., Springer T.A. Integrin structures and conformational signaling. Curr Opin Cell Biol 2006, 5:579-586.
31. Calderwood D.A., Zent R., Grant R., Jasper D., Rees G., Hynes R.O., et al. The talin head domain binds to integrin β-subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999, 274:28071-28074.
32. Harburger D.S., Bouaouina M., Calderwood D.A. Kindlin-1 and -2 directly bind the C-terminal region of β integrin cytoplasmic tails and exert integrin-specific activation effects. J Biol Chem 2009, 284:11485-11497.
33. Moser M., Legate K.R., Zent R., Fässler R. The tail of integrins, talin and kindlins. Science 2009, 324:895-899.
34. Gingras A.R., Ziegler W.H., Bobkov A.A., Joyce M.G., Fasci D., Himmel M., et al. Structural determinants of integrin-binding to the talin rod. J Biol Chem 2009, 284:8866-8876.
35. Labat-Robert J., Potazman J.P., Derouette J.C., Robert L. Age-dependent increase of human plasma fibronectin. Cell Biol Int Rep 1981, 5:969-973.
36. Rasoamanantena P., Thweatt R., Labat-Robert J., Goldstein S. Altered regulation of fibronectin gene expression in Werner syndrome fibroblasts. Exp Cell Res 1994, 213:121-127.
37. Labat-Robert J., Marquès M.A., N'Doye S., Alpérovitch A., Moulias R., Allard, et al. Plasma fibronectin in French centenarians. Arch Gerontol Geriatr 2000, 31:95-105.
38. Bizbiz L., Labat-Robert J., Alperovitch A., Robert L., EVA Group Cardiovascular determinants of plasma fibronectin in an elderly population. The EVA study. Arch Gerontol Geriatr 1997, 25:201-209.
39. Van den Broeck J. Malnutrition and mortality. J Royal Soc Med 1995, 88:487-490.
40. Guigoz Y., Lauque S., Vellas B.J. Identifying the elderly at risk for malnutrition. The mini nutritional assessment. Clin Geriatr Med 2002, 18:737-757.
41. Sandberg L., Van Reken D., Waiwaiku K., Martin-Yeboah P., Weiss C., Updegraff V., et al. Plasma fibronectin levels in acute and recovering malnourished children. Clin Physiol Biochem 1985, 3(5):257-264.
42. Sandberg L.B., Owens A.J., VanReken D.E., Horowitz B., Fredell J.E., Takyi Y., et al. Improvement in plasma protein concentrations with fibronectin treatment in severe malnutrition. Am J Clin Nutr 1990, 52:651-656.
43. Dane C., Buyukasik H., Dane B., Yayla M. Maternal plasma fibronectin and advanced oxidative protein products for the prediction of pre-eclampsia in high risk pregnancies: a prospective cohort study. Fetal Diagn Ther 2009, 26:189-194.
44. Lemanska-Perek A., Leszek J., Kryzanowska-GolabD, Radzik J., Katnik-Praslowska I. Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer's dementia risk. Dement Geriatr Cogn Disord 2009, 28:338-342.
45. Boyer B., Kern P., Fourtanier A., Labat-Robert J. UV-A and UV-B induced changes in collagen and fibronectin biosynthesis in the skin of hairless mice. J Photochem Photobiol B 1992, 14:247-259.
46. Labat-Robert J. Cell-matrix interactions in aging: role of receptors and matricryptins. Aging Res Rev 2004, 3:233-247.
47. de Petro G., Barlati S., Vartio T., Vaheri A. Transformation-enhancing activity of gelatin-binding fragments of fibronectin. Proc Natl Acad Sci U S A 1981, 78:4965-4969.
48. De Petro, Tavian D., Copeta A., Fortolani N., Giulini S.M., Barlati S. Expression of urokinase-type plasminogren activator (u-PA), u-PA receptor and tissue-type PA messenger RNAs in human hepatocellular carcinoma. Cancer Res 1998, 58:2234-2239.
49. Vartio T., Vaheri A., de Petro G., Barlati S. Fibronectin and its proteolytic fragments. Potential as cancer markers. Invasion Metastasis 1983, 3:125-138.
50. Colombi M., Zoppi N., de Petro G., Marchina E., Gardella R., Tavian D., et al. Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide. J Biol Chem 2003, 16:14346-14355.
51. Zoppi N., Ritelli M., Salvi A., Colombi M., Barlati S. The FN13 peptide inhibits human tumor cells invasion through the modulation of ανβ3 integrins organization and the inactivation of ILK pathway. Biochem Biophys Acta 2007, 1773:747-763.
52. Keil-Dlouha V., Planchenault T., Imhoff J.M., Emod I., Blondeau X., Lambert-Vidmar S. Proteolytic potential of fibronectin and degradation of extracellular matrix. Pathol Biol 1990, 38:993-998.
53. Planchenault T., Lambert-Vidmar, Imhoff J.M., Blondeau C., Emod I., Lottspeich F., et al. Potential proteolytic activity of human plasma fibronectin: fibronectin gelatinase. Biol Chem Hoppe-Seyler 1990, 371:117-128.
54. Emod I., Lafaye P., Planchenault T., Lambert-Vidmar S., Imhoff J.M., Keil-Dlouha V. Potential proteolytic activity of fibronectin: fibronectin laminase and its substrate specificity. Biol Chem Hoppe-Seyler 1990, 371:129-135.
55. Homandberg G.A., Davis G., Maniglia C., Shrikhande A. Cartilage chondrolysis by fibronectin-fragments causes cleavage of aggrecan at the same site as found in osteoarthritic cartilage. Osteoarthritis Cartilage 1999, 6:450-453.
56. Xie D., Homandberg G.A. Fibronectin-fragments bind to and penetrate cartilage tissue resulting in proteinase expression and cartilage damage. Biochim Biophys Acta 1993, 1882:189-196.
57. Homandberg G.A. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin-fragments. Front Biosci 1999, 4(D7):13-30.
58. Homandberg G.A. Cartilage damage by matrix degradation products: fibronectin-fragments. Clin Orthop Relat Res 2001, 391S:100-107.
59. Purple C.R., Untermann T.G., Pichika R., Homandberg G.A.G Fibronectin-fragments up-regulate insulin-like growth factor binding proteins in chondrocytes. Osteoarthritis Cartilage 2002, 9:734-746.
60. Ding L., Guo D., Homandberg G.A. The cartilage chondrolytic mechanism of fibronectin-fragments involves MAP kinases: comparison of three fragments and native fibronectin. Osteoarthritis Cartilage 2008, 10:1253-1262.
61. Ding L., Guo D., Homandberg G.A. Fibronectin-fragments mediate matrix metalloproteinases up-regulation and cartilage damage through proline rich tyrosine kinase 2, c-src, NF-kappaB and protein kinase C-delta. Osteoarthritis Cartilage 2009, 10:1385-13892.
62. Homandberg G.A., Meyers R., Williams M. Intra-articular injection of fibronectin-fragments causes severe deletion of cartilage proteoglycan in vivo. J Rheumatol 1993, 20:1378-1382.
63. Werb Z., Tremble P.M., Berhendtsen O., Crowley E., Damski D.H. Signal transduction through the fibronectin receptor induces collagenase and stromelysine gene expression. J Cell Biol 1989, 109:877-889.
64. Yasuda T., Kakinuma T., Julovi S.M., Yoshida M., Hiramitsu T., Akiyoshi M. COOH-terminal heparin-binding fibronectin-fragment induces nitric oxide production in rheumatoid cartilage through CD44. Rheumatology 2004, 43:1116-11120.
65. Yasuda T. Cartilage destruction by matrix degradation products. Mod Rheumatol 2006, 16:197-205.
66. Wysocki A.B., Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990, 63:825-831.
67. Grinnell F., Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α1-proteinase inhibitor, and α2-macroglobulin. J Invest Dermatol 1996, 106:335-341.
68. Stanley C.M., Wang Y., Pal S., Klebe R.J., Harkless L.B., Xu X., et al. Fibronectin fragmentation is a feature of both periodontal disease sites and diabetic foot and leg wounds and modifies cell behavior. J Periodontol 2008, 79:861-875.
69. Davis G.E., Bayless K.J., Davis M.J., Meininger G.A. Regulation of tissue injury response by the exposure of matricryptic sites within extracellular matrix molecules. Proc Natl Acad Sci U S A 2000, 78:4965-4969.